DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Cytarabine (Cytarabine) - Cardiac Failure Congestive - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Cardiac Failure Congestive ()

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cytarabine where reactions include cardiac failure congestive. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Cytarabine side effects in

Reported by a physician from Germany on 2012-06-21

Patient:

Reactions: Alanine Aminotransferase Increased, Arrhythmia, Death, Neurotoxicity, Mucosal Inflammation, Lung Disorder, Aspartate Aminotransferase Increased, Cardiotoxicity, Cardiac Failure Congestive, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Granulocyte Colony Stimulating Factor
    Dosage: induction 2; day 21-28
    Indication: Acute Myeloid Leukaemia

Daunorubicin HCL
    Dosage: induction 2; day 21-28
    Indication: Acute Lymphocytic Leukaemia

Idarubicin HCL
    Dosage: induction 1; day 1

Etoposide
    Dosage: induction 1; day 1
    Indication: Acute Lymphocytic Leukaemia

Cladribine
    Dosage: between days 42-56; consolidation phase
    Indication: Acute Lymphocytic Leukaemia

Cladribine
    Dosage: between days 42-56; consolidation phase
    Indication: Acute Myeloid Leukaemia

Cytarabine
    Dosage: day 42-56 (0.5g/m2), consolidation phase
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: induction 2; high dose; days 21-28

Idarubicin HCL
    Dosage: induction 1; day 1

Etoposide
    Dosage: induction 1; day 1
    Indication: Acute Myeloid Leukaemia

Idarubicin HCL
    Dosage: day 42-56; consolidation phase
    Indication: Acute Myeloid Leukaemia

Granulocyte Colony Stimulating Factor
    Dosage: induction 2; day 21-28
    Indication: Acute Lymphocytic Leukaemia

Daunorubicin HCL
    Dosage: induction 2; day 21-28
    Indication: Acute Myeloid Leukaemia

Cytarabine
    Dosage: day 42-56 (0.5g/m2), consolidation phase
    Indication: Acute Myeloid Leukaemia

Cytarabine
    Dosage: induction 2; high dose; days 21-28

Idarubicin HCL
    Dosage: day 42-56; consolidation phase
    Indication: Acute Lymphocytic Leukaemia

Fludarabine Phosphate
    Dosage: induction 2; day 21-28
    Indication: Acute Myeloid Leukaemia

Cytarabine
    Dosage: induction 1; day 1

Cytarabine
    Dosage: induction 1; day 1

Mitoxantrone
    Dosage: induction 2; day 21-28
    Indication: Acute Lymphocytic Leukaemia

Mitoxantrone
    Dosage: induction 2; day 21-28
    Indication: Acute Myeloid Leukaemia

Fludarabine Phosphate
    Dosage: induction 2; day 21-28
    Indication: Acute Lymphocytic Leukaemia



Possible Cytarabine side effects in 87 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-02

Patient: 87 year old female, weighing 51.3 kg (112.9 pounds)

Reactions: Fluid Overload, Confusional State, Urinary Tract Infection, Anaemia, Syncope, Fungal Infection, Pleural Effusion, Hypoxia, Thrombocytopenia, Pathogen Resistance, Cardiac Failure Congestive

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Decitabine
    Dosage: 20 mg/m2, intravenous
    Indication: Acute Myeloid Leukaemia
    Start date: 2010-03-29
    End date: 2010-04-02

Decitabine
    Dosage: 20 mg/m2, intravenous
    Indication: Acute Myeloid Leukaemia
    Start date: 2010-02-27
    End date: 2010-03-03

Granulocyte Colony Stimulating Ractor (Granulocyte Colony Stimalating
    Dosage: 300 mg, subcutaneous
    Indication: Acute Myeloid Leukaemia
    Start date: 2010-02-27
    End date: 2010-03-03

Granulocyte Colony Stimulating Ractor (Granulocyte Colony Stimalating
    Dosage: 300 mg, subcutaneous
    Indication: Acute Myeloid Leukaemia
    Start date: 2010-03-29
    End date: 2010-04-02

Cytarabine
    Dosage: 20 mg/m2, subcutaneous
    Indication: Acute Myeloid Leukaemia
    Start date: 2010-02-27
    End date: 2010-03-03

Cytarabine
    Dosage: 20 mg/m2, subcutaneous
    Indication: Acute Myeloid Leukaemia
    Start date: 2010-03-29
    End date: 2010-04-02

Other drugs received by patient: Prilosec; Voriconazole; Neutra Phos (Neutra-Phos); Reglan; Potassium Chloride; Propranolol



Possible Cytarabine side effects in 79 year old male

Reported by a physician from Germany on 2012-04-16

Patient: 79 year old male, weighing 80.0 kg (176.0 pounds)

Reactions: Acute Myocardial Infarction, Cardiac Failure Congestive

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vidaza
    Dosage: 140mg daily
    Start date: 2011-11-30
    End date: 2011-12-04

Daunorubicin HCL
    Dosage: 90 milligram/sq. meter
    Start date: 2011-08-29
    End date: 2011-09-04

Vidaza
    Dosage: 140mg daily
    Start date: 2011-10-10
    End date: 2011-10-14

Cytarabine
    Dosage: 200 milligram/sq. meter
    Start date: 2011-08-29
    End date: 2011-09-04

Cytarabine
    Dosage: gram/sqm
    Start date: 2011-10-15
    End date: 2011-10-19

Cytarabine
    Dosage: 1900 milligram
    Start date: 2011-12-09
    End date: 2011-12-09

Cytarabine
    Dosage: 1900 milligram
    Start date: 2011-12-05
    End date: 2011-12-05

Vidaza
    Dosage: 75 milligram/sq. meter
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-08-24
    End date: 2011-08-28

Cytarabine
    Dosage: 1900 milligram
    Start date: 2011-12-07
    End date: 2011-12-07

Other drugs received by patient: Lenograstim; Torsemide; Pantoprazole; Tiotropium Bromide; Delix; Erythrocytes Transfusion; Platelets; Posaconazole; Ceftazidim; Azulfidine; Linezolid; Foradil; Sterofundin; Neupogen; Vergentan



Possible Cytarabine side effects in 79 year old male

Reported by a physician from Germany on 2012-03-15

Patient: 79 year old male, weighing 80.0 kg (176.0 pounds)

Reactions: Acute Myocardial Infarction, Cardiac Failure Congestive

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vidaza
    Dosage: 140mg daily
    Start date: 2011-11-30
    End date: 2011-12-04

Cytarabine
    Dosage: 200 milligram/sq. meter
    Start date: 2011-08-29
    End date: 2011-09-04

Cytarabine
    Dosage: 1900 milligram
    Start date: 2011-12-07
    End date: 2011-12-07

Cytarabine
    Dosage: 1900 milligram
    Start date: 2011-12-09
    End date: 2011-12-09

Daunorubicin HCL
    Dosage: 90 milligram/sq. meter
    Start date: 2011-08-29
    End date: 2011-09-04

Vidaza
    Dosage: 140mg daily
    Start date: 2011-10-10
    End date: 2011-10-14

Cytarabine
    Dosage: gram/sqm
    Start date: 2011-10-15
    End date: 2011-10-19

Cytarabine
    Dosage: 1900 milligram
    Start date: 2011-12-05
    End date: 2011-12-05

Vidaza
    Dosage: 75 milligram/sq. meter
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-08-24
    End date: 2011-08-28

Other drugs received by patient: Pantoprazole; Tiotropium Bromide; Torsemide; Voriconazole; Neupogen; Linezolid; Lenograstim; Platelets; Ceftazidim; Foradil; Ramipril; Azulfidine; Erythrocytes Transfusion; Vergentan; Sterofundin



Possible Cytarabine side effects in 50 year old female

Reported by a physician from United States on 2012-02-14

Patient: 50 year old female

Reactions: Drug Eruption, Renal Failure Chronic, Peripheral Sensory Neuropathy, Thrombocytopenia, Cardiac Failure Congestive

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Etoposide
    Dosage: at 35 years of age
    Indication: Acute Lymphocytic Leukaemia

Elspar

Cytarabine

Vincristine

Cyclophosphamide

Gemcitabine
    Dosage: at 50 years of age (first dose 800 mg/m[to 2nd power])
    Indication: Bile Duct Cancer

Gemcitabine
    Dosage: second dose 600 mg/m[to the 2nd power] 16 days after first dose

Mitoxantrone

Prednisone TAB
    Dosage: at 35 years of age
    Indication: Acute Lymphocytic Leukaemia

Methotrexate



Possible Cytarabine side effects in

Reported by a individual with unspecified qualification from Canada on 2012-02-01

Patient:

Reactions: Cellulitis, Urinary Tract Infection, Clostridium Difficile Colitis, Febrile Neutropenia, Haematotoxicity, Neuropathy Peripheral, Bacteraemia, Oral Candidiasis, Cardiac Failure Congestive

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Burkitt's Lymphoma

Etoposide
    Indication: Burkitt's Lymphoma

Doxorubicin HCL
    Indication: Burkitt's Lymphoma

Vincristine
    Indication: Burkitt's Lymphoma

Cytarabine
    Indication: Burkitt's Lymphoma

Ifosfamide
    Indication: Burkitt's Lymphoma

Mabthera
    Indication: Burkitt's Lymphoma

Methotrexate
    Indication: Burkitt's Lymphoma

Prednisone TAB
    Administration route: Oral
    Indication: Burkitt's Lymphoma



Possible Cytarabine side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-31

Patient: female

Reactions: Cardiac Failure Congestive

Drug(s) suspected as cause:
Vincristine
    Indication: Acute Lymphocytic Leukaemia

Prednisone TAB
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Indication: Acute Lymphocytic Leukaemia

Asparaginase
    Indication: Acute Lymphocytic Leukaemia

Mitoxantrone
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Indication: Acute Lymphocytic Leukaemia

Gemcitabine
    Dosage: first dose
    Indication: Adenocarcinoma

Etoposide
    Indication: Acute Lymphocytic Leukaemia

Cyclophosphamide
    Indication: Acute Lymphocytic Leukaemia



Possible Cytarabine side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-30

Patient: female

Reactions: Cardiac Failure Congestive

Drug(s) suspected as cause:
Etoposide
    Indication: Acute Lymphocytic Leukaemia

Mitoxantrone
    Indication: Acute Lymphocytic Leukaemia

Prednisone TAB
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Indication: Acute Lymphocytic Leukaemia

Asparaginase
    Indication: Acute Lymphocytic Leukaemia

Cyclophosphamide
    Indication: Acute Lymphocytic Leukaemia

Gemcitabine
    Dosage: first dose
    Indication: Adenocarcinoma



Possible Cytarabine side effects in female

Reported by a physician from United States on 2012-01-30

Patient: female

Reactions: Rash, Thrombocytopenia, Cardiac Failure Congestive

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vincristine
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Indication: Acute Lymphocytic Leukaemia

Mitoxantrone
    Indication: Acute Lymphocytic Leukaemia

Cyclophosphamide
    Indication: Acute Lymphocytic Leukaemia

Gemcitabine
    Dosage: first dose
    Indication: Adenocarcinoma

Prednisone TAB
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Indication: Acute Lymphocytic Leukaemia

Asparaginase
    Indication: Acute Lymphocytic Leukaemia

Etoposide
    Indication: Acute Lymphocytic Leukaemia



Possible Cytarabine side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-30

Patient: female

Reactions: Cardiac Failure Congestive

Drug(s) suspected as cause:
Etoposide
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Indication: Acute Lymphocytic Leukaemia

Asparaginase
    Indication: Acute Lymphocytic Leukaemia

Cyclophosphamide
    Indication: Acute Lymphocytic Leukaemia

Prednisone TAB
    Indication: Acute Lymphocytic Leukaemia

Gemcitabine
    Dosage: first dose
    Indication: Adenocarcinoma

Cytarabine
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Indication: Acute Lymphocytic Leukaemia

Mitoxantrone
    Indication: Acute Lymphocytic Leukaemia



Possible Cytarabine side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-29

Patient: female

Reactions: Cardiac Failure Congestive

Drug(s) suspected as cause:
Mitoxantrone
    Indication: Acute Lymphocytic Leukaemia

Cyclophosphamide
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Indication: Acute Lymphocytic Leukaemia

Etoposide
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Indication: Acute Lymphocytic Leukaemia

Prednisone TAB
    Indication: Acute Lymphocytic Leukaemia

Gemcitabine
    Dosage: first dose
    Indication: Adenocarcinoma

Asparaginase
    Indication: Acute Lymphocytic Leukaemia



Possible Cytarabine side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-29

Patient: female

Reactions: Cardiac Failure Congestive

Drug(s) suspected as cause:
Asparaginase
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Indication: Acute Lymphocytic Leukaemia

Cyclophosphamide
    Indication: Acute Lymphocytic Leukaemia

Etoposide
    Indication: Acute Lymphocytic Leukaemia

Mitoxantrone
    Indication: Acute Lymphocytic Leukaemia

Prednisone TAB
    Indication: Acute Lymphocytic Leukaemia

Gemcitabine
    Dosage: first dose
    Indication: Adenocarcinoma



Possible Cytarabine side effects in 50 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-01

Patient: 50 year old female

Reactions: Metastases To Liver, Bile Duct Cancer, Metastases To Stomach, Colonic Polyp, Neuropathy Peripheral, Pleural Effusion, Cardiotoxicity, Thrombocytopenia, Blood Creatinine Increased, Metastases To Lung, Hepatic Cirrhosis, Cardiac Failure Congestive, Bone Marrow Transplant, Blood Urea Increased, Acute Lymphocytic Leukaemia Recurrent, Congestive Cardiomyopathy, Renal Cyst, Toxicity To Various Agents, Rash, Osteosclerosis, Renal Impairment, Diarrhoea, Renal Mass

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vincristine Sulfate
    Dosage: not reported
    Indication: Acute Lymphocytic Leukaemia

Elspar
    Dosage: not reported
    Indication: Acute Lymphocytic Leukaemia

Etoposide
    Dosage: not reported
    Indication: Acute Lymphocytic Leukaemia

Prednisone TAB
    Dosage: not reported
    Indication: Acute Lymphocytic Leukaemia

Cyclophosphamide
    Dosage: not reported
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: not reported
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: not reported, intrathecal
    Indication: Acute Lymphocytic Leukaemia

Mitoxantrone Hydrochloride
    Dosage: not reported
    Indication: Acute Lymphocytic Leukaemia

(Therapeutic Radiopharmaceuticals)
    Dosage: not reported
    Indication: Acute Lymphocytic Leukaemia

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014